Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy

Stroke

Volumn 30, Issue 3, 1999, Pages 556-566

  Sabri, Osama ^a   Ringelstein, Erich Bernhard ^b   Hellwig, Dirk ^b   Schneider, Rolf ^b   Schreckenberger, Mathias ^b   Kaiser, Hans Jürgen ^b   Mull, Michael ^b   Buell, Udalrich ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b NONE

Author keywords

Magnetic resonance imaging; Microangiopathy; Neuropsychological testing; Tomography, emission computed; Vascular dementia

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MICROANGIOPATHY; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

EID: 0033007874     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.3.556     Document Type: Article

References (51)

1. Erkinjuntti T, Hachinski V. Rethinking vascular dementia. Cerebrovasc Dis. 1993;3:3-23.
2. Leys D, Pruvo JP, Scheltens PH, Rondepierre P, Godefroy O, Leclerc X, de Reuck J. Leuko-araiosis: relationship with the types of focal lesions occurring in acute cerebrovascular disorders. Cerebrovasc Dis. 1992;2: 169-176.
3. Filley ChM, Franklin GM, Heaton RK, Rosenberg NL. White matter dementia: clinical disorders and implications. Neuropsychiatry Neuropsychol Behav Neurol. 1989;239-254.
4. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Berl). 1969;12:1-15.
5. Reiche W, Weiller C, Weigmann R, Kaiser HJ, Büll U, Schneider R, Ringelstein EB. Vergleich von MRT- und SPECT-Befunden bei Patienten mit zerebraler Mikroangiopathie. Nuklearmedizin. 1991;30:161-169.
6. Kobari M, Meyer JS, Ichio M. Leuko-araiosis, cerebral atrophy and cerebral perfusion in normal aging. Arch Neurol. 1990;47:161-165.
7. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M. Cerebral blood flow and oxygen consumption in patients with vascular dementia of the Binswanger type. Stroke. 1990;21:1694-1699.
8. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke. 1991; 22:609-614.
9. Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D. Seventy of vascular dementia is related to volume of metabolic impaired tissue. Arch Neurol. 1992;49:909-913.
10. Ringelstein EB, Koschorke S, Holling A, Thron A, Lambertz H, Minale C. CT patterns of proven embolic brain infarctions. Ann Neurol. 1989; 26:759-765.
11. Schneider R, Rademacher M, Wolf S. Lacunar infarcts and white matter attenuation: ophthalmological and microcirculatory aspects of the pathophysiology. Stroke. 1993;24:1874-1879.
12. Ringelstein EB, Weiller C, Weckesser M, Weckesser S. Cerebral vasomotor reactivity is significantly reduced in low-How as compared to thromboembolic infarctions: the key role of the circle of Willis. J Neurol Sci. 1994;121:103-109.
13. Kaiser HJ, Sabri O, Wagenknecht G, Lege B, Hellwig D, Buell U. A method of correlating and merging cerebral morphology and function by a special head holder. Nuklearmedizin. 1994;33:123-126.
14. Phelps ME, Huang SC, Hoffmann EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxyglucose: validation of a method. Ann Neurol. 1979;6:371-388.
15. Reivich M, Alavi A, Wolf AP, Fowler J, Russell, Arnett C, MacGregor RR, Shiue CY, Atkins H, Anand A, Dann R, Greenberg JH. Glucose metabolic rate kinetic model parameter determination in man: the lumped constant and rate constants for (18-F) fluorodeoxyglucose and (11-C) deoxyglucose. J Cereb Blood Flow Metab. 1985;5:179-192.
16. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet. 1997;349: 1735-1739.
17. Talairach J, Szlika G. Atlas d'anatomie stéréotaxique du télencéphale. Paris. France: Masson; 1967.
18. Sturm W, Willmes K, Horn W. Leistungsprüfsystem für 50-90jährige (LPS 50+). Göttingen, Germany: Hogrefe; 1993.
19. Sturm W, Willmes K. Verbaler Lerntest. Mödling, Germany: Schuhfried; 1994.
20. Sturm W, Willmes K. Nonverbaler Lerntest. Mödling, Germany: Schuhfried; 1994.
21. Wechsler D. Wechsler Memory Scale - Revised. New York, NY: Psychological Corporation; 1987.
22. Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Freiburg, Germany: PSYTEST; 1993.
23. von Cramon DY, Mai N, Ziegler W. Neuropsychologische Diagnostik. 1st ed. Weinheim, Germany: VCH; 1993.
24. Becker M, Sturm W, Willmes K, Zimmermann P. Normierungsstudie zur Aufmerksamkeitstestbatterie (TAP) von Zimmermann und Fimm. Z Neuropsychol. 1996;7:3-15.
25. Bortz J. Varianzanalytische Methoden. In: Bortz J, ed. Statistik für Sozialwissenschaftler. 4th ed. Berlin, Germany: Springer; 1993:223-407.
26. Flury B, Riedwyl H. Faktorenanalyse. In: Flury B, Riedwyl H, eds. Angewandte multivariate Statistik. Stuttgart, Germany: Fischer; 1983: 135-149.
27. Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39: 31-36.
28. Guadagnoli E, Velicer WF. Relation of sample size to the stability of component patterns. Psychol Bull. 1988;103:265-275.
29. Torvik A. The pathogenesis of watershed infarctions in the brain. Stroke. 1984;15:221-223.
30. Babikian V, Ropper AH. Binswanger's disease: a review. Stroke. 1987; 18:2-12.
31. Schneider R, Kluge R, Willmes K. Interrater agreement for CT scans of patients with lacunar infarcts and leuko-araiosis. Acta Neurol Scand. 1991;84:527-530.
32. Levasseur M, Baron JC, Sette G, Legault-Démaré F, Pappata S, Mauguière F, Benoît N, Tran Dinh S, Dégos JD, Laplane D, Mazoyer B. Brain energy metabolism in bilateral paramedian thalamic infarcts: a positron emission tomography study. Brain. 1992;115:795-807.
33. Román GC. From UBOs to Binswanger's disease: impact of magnetic resonance imaging on vascular dementia research. Stroke. 1996;27: 1269-1273.
34. Leys D, Pruvo JP, Petit H, Gaudet Y, Clarisse J. Maladie d'Alzheimer: analyse statistique des résultats du scanner X. Rev Neurol (Paris). 1989; 145:134-139.
35. Le May M, Stafford JL, Sándor T, Albert M, Haykal H, Zamani A. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer dementia. J Comput Assist Tomogr. 1986;10:802-809.
36. Laffey PA, Peyster RG, Nathan R, Haskin ME, McGinley JA. Computed tomography and aging: results in a normal elderly population. Neuroradiology. 1984;26:273-278.
37. Chimowitz MI, Awad IA, Furlan AJ. Periventricular lesions on MRI: facts and theories. Stroke. 1989;20:963-967.
38. Fein G, van Dyke C, Davenport L, Turetsky B, Brant-Zawadzki M, Zatz L, Dillon W, Valk P. Preservation of normal cognitive functioning in elderly subjects with extensive white-matter lesions of long duration. Arch Gen Psychiatry. 1990;47:220-223.
39. van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Ramos LM, van Latum JC, van Gijn J. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991;30:825-830.
40. Brust JCM. Vascular dementia reconsidered, part 2. Cerebrovasc Dis. 1993;18:2-12.
41. Drachman DA. New criteria for the diagnosis of vascular dementia: do we know enough yet? Neurology. 1993;43:243-245.
42. O'Brian MB. Vascular dementia reconsidered, part 1. Cerebrovasc Dis. 1993;3:24-25.
43. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, García JH, Amaducci L, Orgogozo JM, Brun A, Hofman A. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
44. DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, Schapiro MB. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology. 1995;45:2077-2084.
45. Meyer E, Delpla P, Pertides E, Ethier R, Bès A, Hakim AM. PET metabolic and neuropsychological correlates of periventricular lucencies. In: Hartmann A, Kuschinsky W, Hoyer S, eds. Cerebral Ischemia and Dementia. Berlin, Germany: Springer-Verlag; 1991:368-373.
46. Mirsen TR, Lee DH, Wong CJ, Díaz JF, Fox AJ, Hachinski VC, Merskey H. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol. 1991;48:1015-1021.
47. Poeck K. Der Beitrag der Neuropsychologie zur Diagnose und Erforschung der Demenzen. In: Häfner H, Hennerici M, eds. Psychische Krankheiten und Hirnfunktion im Alter. Stuttgart, Germany: Gustav Fischer; 1992:91-103.
48. De Reuck J, Decoo D, Strijckmans K, Lemahieu I. Does the severity of leukoaraiosis contribute to senile dementia? A comparative computerized and positron emission tomographic study. Eur Neurol. 1992;32:199-205.
49. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. Stroke. 1996;27:1274-1282.
50. Drayer BP. Imaging of the aging brain, part II: pathological conditions. Radiology. 1988;166:797-806.
51. Yamanouchi H. Loss of white matter oligodendrocytes and astrocytes in progressive subcortical vascular encephalopathy of Binswanger type. Acta Neurol Scand. 1991;83:301-305.